Liminatus Pharma, Inc. (LIMN)

0.2366 +0.01 (+3.32%) USD  |  NASDAQ  |  Feb 23, 16:00
0.233 0.00 (0.00%) Pre-Market: 08:56
More

Liminatus Pharma Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade